Follow us

Experience

a biotechnology company

 in relation to the launch of a new Food for Special Medical Purposes, including the requirements to be classified as such as well as labelling and advertising requirements

a global pharmaceuticals company

in relation to the termination of a licence agreement. In particular, on technical and regulatory issues including the impact of data and marketing exclusivity on the interpretation of the agreement

 

a major global biotech

on regulatory issues related to requirements for, and the interplay between, different paediatric rewards applicable to one of its key orphan drugs

A pharmaceuticals company

specialising in rare diseases on regulatory issues related to the off-label use of medicinal products and right to access to dossiers submitted to the EMA for medicinal product approval

a major global biotech

on pricing and reimbursement issues for some of its key productions, including the application of reimbursement linkage provisions and hospital tender requirements

Ariosa Diagnostics

on the impact of regulatory issues (including CE-marking) on patent litigation concerning their Harmony® non-invasive prenatal diagnostic test


Resources

Stay in the know

We’ll send you the latest insights and briefings tailored to your needs

Key contacts

Laura Orlando photo

Laura Orlando

Italy Managing Partner, Joint Global Head of Intellectual Property, EMEA Co-Head of Life Sciences, Milan

Laura Orlando
Rebekah Gay photo

Rebekah Gay

Partner and Joint Global Head of Intellectual Property, Sydney

Rebekah Gay
Dr Ina vom Feld photo

Dr Ina vom Feld

Partner, Germany

Dr Ina vom Feld
Jonathan Turnbull photo

Jonathan Turnbull

Partner, London

Jonathan Turnbull
Frédéric Chevallier photo

Frédéric Chevallier

Partner, Paris

Frédéric Chevallier
Sebastian Moore photo

Sebastian Moore

Partner and Head of Intellectual Property, UK, London and Milan

Sebastian Moore
Emma Iles photo

Emma Iles

Partner, Melbourne

Emma Iles